The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on October 16, 2025

October 16, 2025

AVITA Medical Announces CEO Transition

GlobeNewswire

October 16, 2025

Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)

GlobeNewswire

October 16, 2025

Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

October 16, 2025

Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details

GlobeNewswire

October 16, 2025

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

GlobeNewswire

October 16, 2025

atai Life Sciences Announces Proposed Public Offering of Common Shares

GlobeNewswire

October 16, 2025

atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression

GlobeNewswire

October 16, 2025

WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective October 21, 2025

GlobeNewswire

October 16, 2025

LifeStance to Host Third Quarter 2025 Earnings Conference Call on November 6, 2025

GlobeNewswire

October 16, 2025

Lite Strategy Celebrates 14th Anniversary of Litecoin, Taps Institutional Signals Ahead of 2026

GlobeNewswire

October 16, 2025

RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting

GlobeNewswire

$Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update$

October 16, 2025

Artiva Biotherapeutics Announces Refractory Rheumatoid Arthritis as Lead Indication, Upcoming Data Releases, and Corporate Update

GlobeNewswire

October 16, 2025

I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences

GlobeNewswire

October 16, 2025

Galapagos kondigt benoeming aan van Fred Blakeslee als General Counsel

GlobeNewswire

October 16, 2025

Praxis Precision Medicines, Inc. Announces Proposed Public Offering

GlobeNewswire

October 16, 2025

Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL

GlobeNewswire

$AB Science provides intitial Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia$

October 16, 2025

AB Science provides intitial Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia

GlobeNewswire

$AB Science présente les premières données de phase 1 de la combinaison d’AB8939 et du venetoclax dans le traitement de la leucémie myéloïde aiguë réfractaire ou en rechute$

October 16, 2025

AB Science présente les premières données de phase 1 de la combinaison d’AB8939 et du venetoclax dans le traitement de la leucémie myéloïde aiguë réfractaire ou en rechute

GlobeNewswire

October 16, 2025

Wounded Warriors Family Support Donates 2025 Ford F-150 Truck to Retired Marines Veteran

GlobeNewswire

October 16, 2025

Global Anti-Parkinson's Drugs Markets Projected to Reach $9.2 Billion by the End of 2030

GlobeNewswire